Lung MRI in the Management of Idiopathic Pulmonary Fibrosis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DEVICE

MRI

It will be performed on a 1.5-Tesla MR scanner (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany). Acquisitions will be obtained in the axial plane using a 12-channel thorax/spine coil. Investigators will use previously published sequence parameters for each MRI sequence. PETRA will be acquired under free-breathing with respiratory gating at functional respiratory capacity.

OTHER

Thoracic HRCT (standard reference)

It will be performed on a 16 (Sensation 16, Siemens®) or 64 channels (Definition 64, Siemens®), without contrast agent injection.

Trial Locations (1)

33604

CHU de Bordeaux, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03078426 - Lung MRI in the Management of Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter